Semaglutide vs Tirzepatide: Which Weight Loss Medication Is Right for You?

If you're researching weight loss medications, you've likely encountered two names repeatedly: semaglutide and tirzepatide. Both are weekly injections that have revolutionized medical weight loss, but they work differently and produce different results. Understanding the differences can help you and your clinician choose the right one for your goals.

Let's break down how these medications compare across the factors that matter most: effectiveness, side effects, cost, and accessibility.

How They Work: The Science Behind Each Medication

Semaglutide (sold as Wegovy for weight loss and Ozempic for diabetes) is a GLP-1 receptor agonist. It mimics the GLP-1 hormone that your body naturally produces after eating, signaling fullness to your brain and slowing stomach emptying.

Tirzepatide (sold as Zepbound for weight loss and Mounjaro for diabetes) goes a step further — it's a dual GIP/GLP-1 receptor agonist. This means it targets both GLP-1 and GIP receptors, providing more powerful appetite suppression and better metabolic effects.

Think of it like this: semaglutide works on one hormone pathway, while tirzepatide works on two. In clinical trials, this dual mechanism has translated to significantly greater weight loss.

Effectiveness: The Numbers Don't Lie

Both medications deliver impressive results, but tirzepatide consistently outperforms semaglutide in head-to-head comparisons:

• Tirzepatide (Zepbound): 18–22.5% average body weight loss over 72 weeks
• Semaglutide (Wegovy): 15–17% average body weight loss over 68 weeks

In the SURPASS-2 clinical trial directly comparing the two medications, tirzepatide patients lost an average of 5 pounds more than semaglutide patients at the same dose level. At the highest doses, the difference was even more pronounced.

However, both medications represent a massive improvement over older weight loss treatments. Before GLP-1 medications, the most effective pharmaceutical options produced only 5–10% weight loss — and often came with significant side effects.

Side Effects: What You Need to Know

Both medications cause similar side effects, primarily gastrointestinal:

• Nausea (most common, usually resolving within 2–3 weeks)
• Diarrhea or constipation
• Abdominal discomfort or bloating
• Decreased appetite

The good news: these side effects are typically mild and transient. The gradual dose escalation used with both medications helps minimize discomfort as your body adjusts.

Some patients tolerate one medication better than the other. If you've tried semaglutide and struggled with side effects, tirzepatide may be worth trying — and vice versa. The mechanisms are different enough that some patients who experience issues with one may do well with the other.

Both medications carry the same contraindication: avoid if you have a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).

Cost Comparison: Breaking Down the Prices

Without insurance, both medications are expensive — brand-name retail prices run $1,000–$1,350 per month. However, there are more affordable options:

• Brand-name (retail pharmacy): $1,000–$1,350/month
• With insurance: $25–300/month (coverage varies significantly)
• Compounded (telehealth clinics): $99–$399/month through FDA-regulated compounding pharmacies

Telehealth platforms like LAVIA offer compounded versions of both semaglutide and tirzepatide at a fraction of the brand-name cost — making either medication accessible without insurance.

Which One Is Right for You?

There's no single "best" medication for everyone. The right choice depends on your specific situation:

Choose Tirzepatide if:

• You want the maximum possible weight loss
• You didn't achieve desired results with semaglutide
• You're comfortable with the higher potency

Choose Semaglutide if:

• You want a well-established medication with longer availability
• You've had gastrointestinal issues with other medications
• Your clinician recommends it based on your medical history

Both medications require a prescription and ongoing clinical supervision. The best way to determine which is right for you is through a consultation with a licensed healthcare provider who can assess your medical history, goals, and contraindications.

Get Started with a Consultation

LAVIA offers both semaglutide and tirzepatide through our telehealth platform. Our licensed clinicians will evaluate your health profile and recommend the medication and dosage best suited to your needs — all from the comfort of your home.

Take our 5-minute online qualification today to find out which medication might be right for you.